| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |